Table 13Risk classification of Oncotype DX™ against the St. Gallen criteria

St. Gallen risk group10 yr. risk of distant relapse by St. GallenOncotype DX Risk group10 yr. risk of distant relapse% of St. Gallen stratum (n)
Low5%Low 0% 72% (38)
(n=53)Medium 18% 22% (12)
8%High43%6% (3)
Intermediate9%Low 5% 60% (134)
(n=222)Medium 6% 23% (51)
33%High21%17% (37)
High18%Low 8% 42% (134)
(n=393)Medium 18% 22% (51)
59%High33%36% (37)

From: 3, Results

Cover of Impact of Gene Expression Profiling Tests on Breast Cancer Outcomes
Impact of Gene Expression Profiling Tests on Breast Cancer Outcomes.
Evidence Reports/Technology Assessments, No. 160.
Marchionni L, Wilson RF, Marinopoulos SS, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.